SEC Form 4 · accession 0001203311-16-000179
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Dobmeier
Officer — Chief Operating Officer
Period of report
Dec 8, 2016
Accepted (ET)
Dec 12, 2016 · 7:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 8, 2016 | M | 2,800 | $20.52 | A | 90,567 | D | |
| Common StockF2,F1 | Dec 8, 2016 | S | 2,800 | $66.003 | D | 87,767 | D | |
| Common StockF1 | Dec 8, 2016 | M | 9,700 | $20.52 | A | 97,467 | D | |
| Common StockF3,F1 | Dec 8, 2016 | S | 9,700 | $65.9004 | D | 87,767 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $20.52 | Dec 8, 2016 | M | 2,800 | D | — | Jun 30, 2021 | Common Stock | 2,800 | 9,700 | D |
| Non-Qualified Stock Option (right to buy)F4 | $20.52 | Dec 8, 2016 | M | 9,700 | D | — | Jun 30, 2021 | Common Stock | 9,700 | 0 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $66.00 to $66.035. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F3Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $65.90 to $65.91. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F4Shares vested at a rate of 25% on 6/30/2012 and monthly thereafter until all the shares were fully vested on 6/30/15.